|
|
|
Who are the proposed constituents?
|
Include but not limited to:
| FDA |
| |
CDRH |
Center for Devices and
Radiological Health |
| |
CDER |
Center for Drug Evaluation and Research |
| CDC |
| |
DHQP |
Division of Healthcare Quality Promotion,
Prevention, and Evaluation Branch |
| NIH |
| |
NIAID |
National Institute of Allergy and
Infectious Diseases |
- Device-manufacturing companies
- Drug-manufacturing companies
- Physicians (various medical & surgical subspecialties
- Infection Control Practitioners
- Nurses
- Clinical Pharmacists
- Researchers
This will include various societies comprised of medical, surgical, nursing and infection control specialists.
|
|
 |
MADRI: Multidisciplinary Alliance Against Device-Related Infections.
|
Welcome
to MADRI
What is MADRI?
MADRI is a platform to link governmental agencies, industrial
entities, medical societies and healthcare providers.
This link will provide a mechanism to discuss, share information,
and develop strategies for prevention and treatment of
device-related infections.
Why is MADRI needed?
Infection is the most common serious complication of medical
devices. At least one-half of all cases of nosomial infections
are device-associated. Currently, there is a progressive
trend for invasive insertion of an increasing number of
medical devices. Population trends have also changed and
now are comprised of older and more immunocompromised
patients. With these changes it is anticipated that there
will be further amplification of device-related infections.
Aren’t these issues currently being addressed?
Yes, through various entities that include governmental
agencies, industry, medical societies, and healthcare
providers. Although potentially useful, these approaches
are not optimal due to: suboptimal multidisciplinary interactions;
major focus on catheters with much less focus on surgical
implants,; and inefficient interaction between device-manufacturing
and drug-manufacturing companies.
|
|
 |
What
are the proposed objectives of this alliance? |
|
To discuss the governmental, industrial, and medical perspectives
regarding the development of devices and antimicrobial
agents that may serve to better prevent or treat device-related
infections. |
|
Allow constituents
to share evolving medical information on a particular
type of device or drug with other constituents. |
|
Organize groups that
have an interest in the study of particular types of device-related
infection. |
|
Construct multidisciplinary
approaches for the prevention and treatment of infections
associated with various types of medical devices. |
|
 |
|
CONTACT INFO
Donna JonesDept PMR
1333 Moursund Avenue A-221, Houston Texas 77030
Phone: 713.799.5086
Email:
djones@bcm.tmc.edu
Program Director
Rabih O. Darouiche, MD
Professor and Director
Center for Prostheses Infection
|
| |
|
|
